Carl L Gordon's Net Worth
$553 Million
Who is Carl L Gordon?
Carl L Gordon has an estimated net worth of $553 Million. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., ArriVent Biopharma, Inc., COMPLETE GENOMICS INC, Turning Point Therapeutics, Inc., AMARIN CORP PLC\UK, Keros Therapeutics, Inc., Intellia Therapeutics, Inc., Theseus Pharmaceuticals, Inc., Alector, Inc., Kinnate Biopharma Inc., SpringWorks Therapeutics, Inc., ACADIA PHARMACEUTICALS INC, Pacira Pharmaceuticals, Inc., BIOCRYST PHARMACEUTICALS INC, ARMO BioSciences, Inc., Prevail Therapeutics Inc., Gemini Therapeutics, Inc. /DE, BiomX Inc., SELECTA BIOSCIENCES INC, Terns Pharmaceuticals, Inc., Oric Pharmaceuticals, Inc., Compass Therapeutics, Inc., Arsanis, Inc., and ACCELERON PHARMA INC.
SEC CIK
Carl L Gordon's CIK is 0001282930
Past Insider Trading and Trends
2023 was Carl L Gordon's most active year for acquiring shares with 36 total transactions. Carl L Gordon's most active month to acquire stocks was the month of January. 2011 was Carl L Gordon's most active year for disposing of shares, totalling 48 transactions. Carl L Gordon's most active month to dispose stocks was the month of February. 2019 saw Carl L Gordon paying a total of $29,302,284.00 for 26,549,042 shares, this is the most they've acquired in one year. In 2018 Carl L Gordon cashed out on 8,255,806 shares for a total of $206,125,690.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adicet Bio, Inc. (ACET) Snapshot price: $3.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 21
| |||
Form 4
| +100.00% | 5.9K |
—
|
—
| 11.8K |
Jun 5
| |||
Form 4
| +47.01% | 3.13M |
$2.40 | $7,500,000.00 | 9.77M |
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
| +12.10% | 875K |
$2.09 | $1,828,750.00 | 8.11M |
Jun 27
| |||
Form 4
|
∞
| 5.9K |
—
|
—
| 5.9K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
| +765.30% | 214.28K |
$14.00 | $2,999,990.00 | 242.28K |
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
| +10.25% | 524.35K |
$13.00 | $6,816,537.00 | 5.64M |
Feb 12
| |||
Form 4
|
∞
| 6.02M |
—
|
—
| 6.02M |
Sep 15 - Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ArriVent Biopharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +143.25% | 3.03M |
$18.00 | $3,999,996.00 | 5.14M |
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
COMPLETE GENOMICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Turning Point Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
∞
| 2.03M |
$18.00 |
—
| 2.03M |
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AMARIN CORP PLC\UK (AMRN) Snapshot price: $1.195
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -28.03% | -233.70K |
$14.43 | -$3,372,992.10 | 600K |
Scheduled
|
Sep 4
| ||
Form 4
| -30.53% | -366.30K |
$14.61 | -$5,350,690.62 | 833.7K |
Scheduled
|
Jul 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 4
| -33.96% | -617.10K |
$14.46 | -$7,986,701.24 | 1.2M |
Jun 19
| |||
Form 4
| -3.50% | -132.90K |
$16.16 | -$2,137,270.00 | 3.67M |
Apr 29 - May 2
| |||
Form 4/A
| -22.86% | -800.00K |
$15.79 | -$12,632,000.00 | 2.7M |
Apr 20
| |||
Form 4
| -14.56% | -750.00K |
$16.54 | -$12,500,000.00 | 4.4M |
Apr 21
| |||
Form 4
| -20.85% | -3.80M |
$15.64 | -$58,181,898.51 | 14.43M |
Scheduled
|
Apr 18 - Apr 20
| ||
Form 4
| -0.87% | -173.00K |
$7.44 | -$1,281,828.00 | 19.74M |
Mar 24 - Mar 28
| |||
Form 4
| -1.14% | -77.00K |
$7.05 | -$542,850.00 | 6.67M |
Mar 21
| |||
Form 4
| -1.09% | -225.00K |
$7.33 | -$1,654,750.00 | 20.43M |
Mar 11 - Mar 15
| |||
Form 4
| -0.36% | -75.00K |
$7.69 | -$573,980.00 | 21.02M |
Mar 3 - Mar 7
| |||
Form 4
| -1.13% | -245.00K |
$7.67 | -$1,884,400.00 | 21.39M |
Feb 28 - Mar 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |